WHO ICTRP trial
Effects of SLCO1B1 Polymorphism and Pitavastatin on the Pharmacokinetics of…
ChiCTR-TRC-11001742 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-11001742 |
|---|---|
| Public title | Effects of SLCO1B1 Polymorphism and Pitavastatin on the Pharmacokinetics of Repaglinide in Chinese Healthy Volunteers |
| Scientific title | Effects of SLCO1B1 Polymorphism and Pitavastatin on the Pharmacokinetics of Repaglinide in Chinese Healthy Volunteers |
| Primary sponsor | Third Xiangya Hospital, Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | No |
| Interventions | group 1:4 mg pitavastatin calcium+4mg repaglinide;group 2:Placebo+4mg repaglinide |
| Registration date | Nov 29, 2011 |
| Target size | group 1:6;group 2:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: